DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

JP Morgan Maintains Neutral on Nektar Therapeutics, Lowers Price Target to $27

JP Morgan maintains Nektar Therapeutics (NASDAQ:NKTR) with a Neutral and lowers the price target from $28 to $27.

Benzinga · 03/09/2020 12:21

JP Morgan maintains Nektar Therapeutics (NASDAQ:NKTR) with a Neutral and lowers the price target from $28 to $27.